Multi-biomarker approach for estimating population size in a national-scale wastewater-based epidemiology study

This study identifies biochemical markers (BCIs) that can be used as population markers in wastewater-based epidemiology (WBE) and compares their estimates with other established population size estimation (PE) methods, including census data (PE<sub>CEN</sub>). Several groups of BCIs (64 targets: genetic and chemical markers) were investigated in an intercity study, including 10 cities/towns within England equating to a population of ∼7 million people. Several selection criteria were applied to identify the best BCIs to provide robust estimation of population size at a catchment level: (1) excellent performance with analytical methods; (2) excellent fit of the linear regression model which indicates PE-driven BCI daily loads; (3) low temporal variability in usage; (4) human-linked origin. Only a few tested BCIs showed a strong positive linear correlation between daily BCI loads and PE indicating their low spatiotemporal variability. These are: cimetidine, clarithromycin, metformin, cotinine, bezafibrate, metronidazole and hydroxymetronidazole, diclofenac, and benzophenone 1. However, only high/long term usage pharmaceuticals: cimetidine and metformin as well as cotinine (metabolite of nicotine) performed well when tested in two independent datasets and catchments accounting for both spatial and temporal scales. Strong seasonal usage trends were observed for antihistamines, NSAIDs (anti-inflammatories), antibiotics and UV filters, invalidating them as PE markers. Key conclusions from the study are: (1) Cimetidine is the best performing BCI; (2) Chemical markers outperform genetic markers as PE BCIs; (3) Water utility PE estimates (PE<sub>WW</sub>) align well with PE<sub>CEN</sub> and PE<sub>BCI</sub> values; (4) Ammonium/orthophosphate as well as viral PE markers suffer from high temporal variability, hence, they are not recommended as PE<sub>BCI</sub> markers, and, most importantly, (5) PE<sub>BCI</sub> calibration/validation at the country/region level is advised in order to establish the best PE markers suited for local/national needs and accounting for site/region specific uncertainties.

Authors

Institutions

Publication Details

Journal
Water Research
Published
2024-10-09
DOI
https://doi.org/10.1016/j.watres.2024.122527
Citations
3
Primary Topic
SARS-CoV-2 detection and testing
Type
article
Field-Weighted Citation Impact
1.17

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multi-biomarker approach for estimating population size in a national-scale wastewater-based epidemiology study

Kata Farkas, Matthew J. Wade, Natalie Sims, Barbara Kasprzyk‐Hordern et al.
3 citations
Water Research
SARS-CoV-2 detection and testing
1.17
article

Multi-biomarker approach for estimating population size in a national-scale wastewater-based epidemiology study

Kata Farkas, Matthew J. Wade, Natalie Sims, Barbara Kasprzyk‐Hordern, Megan Robertson, Davey L. Jones, Kishore Jagadeesan, John Bagnall, Kathryn Proctor
article en
3 citations

Abstract

This study identifies biochemical markers (BCIs) that can be used as population markers in wastewater-based epidemiology (WBE) and compares their estimates with other established population size estimation (PE) methods, including census data (PE<sub>CEN</sub>). Several groups of BCIs (64 targets: genetic and chemical markers) were investigated in an intercity study, including 10 cities/towns within England equating to a population of ∼7 million people. Several selection criteria were applied to identify the best BCIs to provide robust estimation of population size at a catchment level: (1) excellent performance with analytical methods; (2) excellent fit of the linear regression model which indicates PE-driven BCI daily loads; (3) low temporal variability in usage; (4) human-linked origin. Only a few tested BCIs showed a strong positive linear correlation between daily BCI loads and PE indicating their low spatiotemporal variability. These are: cimetidine, clarithromycin, metformin, cotinine, bezafibrate, metronidazole and hydroxymetronidazole, diclofenac, and benzophenone 1. However, only high/long term usage pharmaceuticals: cimetidine and metformin as well as cotinine (metabolite of nicotine) performed well when tested in two independent datasets and catchments accounting for both spatial and temporal scales. Strong seasonal usage trends were observed for antihistamines, NSAIDs (anti-inflammatories), antibiotics and UV filters, invalidating them as PE markers. Key conclusions from the study are: (1) Cimetidine is the best performing BCI; (2) Chemical markers outperform genetic markers as PE BCIs; (3) Water utility PE estimates (PE<sub>WW</sub>) align well with PE<sub>CEN</sub> and PE<sub>BCI</sub> values; (4) Ammonium/orthophosphate as well as viral PE markers suffer from high temporal variability, hence, they are not recommended as PE<sub>BCI</sub> markers, and, most importantly, (5) PE<sub>BCI</sub> calibration/validation at the country/region level is advised in order to establish the best PE markers suited for local/national needs and accounting for site/region specific uncertainties.

Water ResearchVol. 268(Pt A)
European Medicines Agency (NL), Bangor University (GB), University of Bath (GB)
Sight Research UK, Engineering and Physical Sciences Research Council, Natural Environment Research Council
Clean water and sanitation
Openalex Percentile: Top 21%
SARS-CoV-2 detection and testing
1.17
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.